We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

56 hedge funds and large institutions have $380M invested in Nautilus Biotechnolgy in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

130% more capital invested

Capital invested by funds: $165M → $380M (+$214M)

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

50% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 10

27% more funds holding

Funds holding: 44 → 56 (+12)

18% more call options, than puts

Call options by funds: $294K | Put options by funds: $250K

46.2% less ownership

Funds ownership: 77.66% → 31.46% (-46%)

Holders
56
Holders Change
+12
Holders Change %
+27.27%
% of All Funds
0.97%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
24
Increased
15
Reduced
10
Closed
12
Calls
$294K
Puts
$250K
Net Calls
+$44K
Net Calls Change
+$46K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$96.5M
2
MVG
Madrona Venture Group
Washington
+$65.2M
3
CFM
Comprehensive Financial Management
California
+$24.1M
4
ABG
Ally Bridge Group
New York
+$16.2M
5
RCM
RA Capital Management
Massachusetts
+$16.2M

Top Sellers

Rank Fund Capital Flow
1
AWG
Alpha Wave Global
New York
-$8.39M
2
BCM
BlueCrest Capital Management
Jersey
-$7.78M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.77M
4
ESCM
Echo Street Capital Management
New York
-$3.95M
5
ACM
Altium Capital Management
New York
-$3.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$90M +$96.5M +8,911,151 New
MVG
2
Madrona Venture Group
Washington
$47.8M +$65.2M +6,020,770 New
RCM
3
RA Capital Management
Massachusetts
$25M +$16.2M +1,500,000 +154%
CFM
4
Comprehensive Financial Management
California
$22.5M +$24.1M +2,224,619 New
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$20.2M +$10.8M +1,000,000 +100%
O
6
OrbiMed
New York
$15.6M +$16.2M +1,497,325 +3,033%
ABG
7
Ally Bridge Group
New York
$15.2M +$16.2M +1,500,000 New
ACI
8
Amazon.com Inc
Washington
$14.7M +$15.8M +1,457,055 New
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$13.5M +$7.24M +668,648 +90%
NCM
10
Nantahala Capital Management
Connecticut
$12M +$5.24M +484,040 +68%
APM
11
Avidity Partners Management
Texas
$11.4M +$6.77M +625,000 +125%
RI
12
RTW Investments
New York
$10.4M +$6.5M +600,000 +120%
BlackRock
13
BlackRock
New York
$10.1M -$34.7K -3,203 -0.3%
AAA
14
Affinity Asset Advisors
New York
$9.09M +$2.29M +211,000 +31%
Federated Hermes
15
Federated Hermes
Pennsylvania
$8.08M – – –
SFM
16
Sphera Funds Management
Israel
$8.08M +$4.33M +400,000 +100%
BC
17
Boxer Capital
California
$7.58M +$8.12M +750,000 New
Franklin Resources
18
Franklin Resources
California
$5.05M – – –
CC
19
Casdin Capital
New York
$5.05M +$5.42M +500,000 New
RCMNY
20
Rubric Capital Management (New York)
New York
$3.65M +$3.91M +361,144 New
SCM
21
Suvretta Capital Management
New York
$3.18M +$3.25M +300,000 +2,022%
BOTOTLSJU
22
Board of Trustees of The Leland Stanford Junior University
California
$3.13M +$3.35M +309,492 New
6CM
23
683 Capital Management
New York
$2.7M – – –
PVI
24
Pura Vida Investments
New York
$2.09M -$958K -88,475 -30%
HC
25
Hillman Company
Pennsylvania
$2.02M +$2.17M +200,000 New
1
2 3

NAUT Hedge Fund Activity: Q2 2021 in Review

56 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q2 2021, worth a combined $380M — up 130% from $165M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NAUT positions and 12 closed out — a net gain of 12 holders — while 15 added to existing stakes and 10 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $96.5M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $8.39M sold.

  • 56 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q2 2021, up from 44 in Q1 2021.
  • Funds reported $380M of Nautilus Biotechnolgy stock for Q2 2021, up 130% quarter-over-quarter.
  • 24 funds opened new Nautilus Biotechnolgy positions in Q2 2021 and 12 closed out, a net change of +12 holders.
  • The largest Nautilus Biotechnolgy buyer in Q2 2021 was Perceptive Advisors, an estimated $96.5M added.
  • The largest Nautilus Biotechnolgy seller in Q2 2021 was Alpha Wave Global, an estimated $8.39M sold.

Based on aggregated 13F filings for Q2 2021.